Bogus HIV tests
This article was originally published in The Gray Sheet
Executive SummaryFederal Trade Commission charges David Rothbart, doing business as Medimax, Inc., with falsely representing on the Internet that his tests accurately detect HIV. At the request of the FTC, a federal district court in Orlando, Florida has issued a temporary restraining order against Rothbart. The agency's complaint seeks to permanently enjoin Rothbart and require payment of "consumer redress." Separately, Cyberlinx Marketing settled FTC charges earlier this month that the Internet company falsely represented its HIV home test kits as accurately detecting HIV. Under the stipulated final settlement order, Cyberlinx and its president, Jeffrey Stein, are banned from marketing HIV home test kits and must reimburse the money received from the sale of the kits
You may also be interested in...
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a CDC says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.